找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Advances in Tumor Immunology and Immunotherapy; Joseph D. Rosenblatt,Eckhard R. Podack,Augusto Och Book 2014 Springer Science+Business Med

[復(fù)制鏈接]
查看: 45718|回復(fù): 56
樓主
發(fā)表于 2025-3-21 18:20:26 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
期刊全稱Advances in Tumor Immunology and Immunotherapy
影響因子2023Joseph D. Rosenblatt,Eckhard R. Podack,Augusto Och
視頻videohttp://file.papertrans.cn/151/150044/150044.mp4
發(fā)行地址Most up-to-date volume that explores evolving paradigms in antigen presentation, dendritic cell biology, the innate response and immunosuppressive mechanisms, and emerging strategies for manipulation
學(xué)科分類Current Cancer Research
圖書封面Titlebook: Advances in Tumor Immunology and Immunotherapy;  Joseph D. Rosenblatt,Eckhard R. Podack,Augusto Och Book 2014 Springer Science+Business Med
影響因子.Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. .Enhanced understanding of mechanisms underlying T-cell anergy such as arginine deprivation, immunosuppressive cytokines, defective innate and interferon response pathways, and NKG2D downregulation have all provided new insight into suppression of anti-tumor immunity and tumor evasion. .In addition to emerging understanding of tumor evasion, new immune targets such as CTLA4 blockade, NK stimulatory receptors, manipulation of the antigen processing and presentation, cytokine and costimulatory responses all provide new possibilities for enhancing anti-tumor immunity even in tumors previously felt to be resistant to immune attack. Several of these strategies have already been realized in the clinic. The volume will explore evolving paradigms in antigen presentation, dendritic cell biology, the innate response and immunosuppressive mechanisms, and
Pindex Book 2014
The information of publication is updating

書目名稱Advances in Tumor Immunology and Immunotherapy影響因子(影響力)




書目名稱Advances in Tumor Immunology and Immunotherapy影響因子(影響力)學(xué)科排名




書目名稱Advances in Tumor Immunology and Immunotherapy網(wǎng)絡(luò)公開度




書目名稱Advances in Tumor Immunology and Immunotherapy網(wǎng)絡(luò)公開度學(xué)科排名




書目名稱Advances in Tumor Immunology and Immunotherapy被引頻次




書目名稱Advances in Tumor Immunology and Immunotherapy被引頻次學(xué)科排名




書目名稱Advances in Tumor Immunology and Immunotherapy年度引用




書目名稱Advances in Tumor Immunology and Immunotherapy年度引用學(xué)科排名




書目名稱Advances in Tumor Immunology and Immunotherapy讀者反饋




書目名稱Advances in Tumor Immunology and Immunotherapy讀者反饋學(xué)科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 20:43:30 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:22:43 | 只看該作者
地板
發(fā)表于 2025-3-22 05:08:56 | 只看該作者
5#
發(fā)表于 2025-3-22 08:44:54 | 只看該作者
Induction of Tumor Immunity by Targeted Inhibition of Nonsense-Mediated mRNA Decayty of the tumor provides the time and opportunity for the tumor to elaborate immune evasion mechanisms. Weak antigenicity is, therefore, the root cause why tumors escape immune control. We have recently described a way to activate the antitumor immune response that is fundamentally different from cu
6#
發(fā)表于 2025-3-22 14:02:21 | 只看該作者
7#
發(fā)表于 2025-3-22 20:20:27 | 只看該作者
8#
發(fā)表于 2025-3-23 00:17:51 | 只看該作者
9#
發(fā)表于 2025-3-23 05:21:04 | 只看該作者
10#
發(fā)表于 2025-3-23 09:07:49 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-21 20:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
含山县| 岐山县| 平乐县| 灵川县| 夏津县| 金寨县| 治多县| 吉木乃县| 土默特左旗| 岳池县| 犍为县| 鸡西市| 江山市| 汾西县| 尼勒克县| 三河市| 武定县| 革吉县| 任丘市| 凤冈县| 保亭| 平利县| 大丰市| 本溪| 海阳市| 宣威市| 桃江县| 乐安县| 麦盖提县| 虞城县| 财经| 临邑县| 广宗县| 邛崃市| 克什克腾旗| 江川县| 密山市| 东乡族自治县| 西畴县| 乐东| 蒙自县|